Isolated systolic hypertension: an important cardiovascular risk factor
Related Experiment Video
Updated: Oct 24, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
A Himmelmann1, T Hedner, L Hansson
1Department of Clinical Pharmacology, Sahlgrenska University Hospital, Göteborg, Sweden. anders.himmelmann@pharm.gu.se
Insights
Treating borderline isolated systolic hypertension is crucial for preventing cardiovascular disease deaths. Mildly elevated systolic blood pressure significantly increases mortality risk, especially in older adults.
Area of Science:
- Cardiology
- Public Health
- Gerontology
Background:
- Hypertension is a major risk factor for cardiovascular disease (CVD) morbidity and mortality.
- Treatment of diastolic blood pressure has proven benefits; isolated systolic hypertension is also now recognized as important.
- Mild elevations in systolic blood pressure, particularly in older adults, are associated with excess CVD risk.
Purpose of the Study:
- To highlight the significance of borderline isolated systolic hypertension as a critical public health challenge.
- To emphasize the need for effective prevention and control strategies for elevated systolic blood pressure.
Main Methods:
- Analysis of data from large-scale epidemiological studies, including the Multiple Risk Factor Intervention Trial and the Framingham Heart Study.
- Examination of age-related hemodynamic changes, specifically increased large artery stiffness.
Main Results:
- The majority of excess cardiovascular deaths occur in individuals with high-normal systolic blood pressure or stage 1 hypertension (130-159 mmHg).
- Mild systolic blood pressure elevations are strongly linked to increased CVD risk, as shown in multiple cohort studies.
- Borderline isolated systolic hypertension becomes the predominant form of hypertension with increasing age due to arterial stiffening.
Conclusions:
- Preventing and controlling borderline isolated systolic hypertension is a key strategic goal for reducing cardiovascular mortality.
- Addressing even mild elevations in systolic blood pressure is essential for comprehensive cardiovascular disease prevention efforts.
Abstract:
Hypertension is an established risk factor for cardiovascular disease morbidity and mortality. Randomized trials of antihypertensive therapy have demonstrated the benefits of treating diastolic blood pressure, and recently the value of treating isolated systolic blood pressure has also been established. There is an excess risk of cardiovascular disease in subjects with borderline isolated systolic hypertension. In fact, data from men screened for the Multiple Risk Factor Intervention Trial show that the great majority of excess deaths are in those with high-normal systolic blood pressure or with stage 1 hypertension, i.e., systolic blood pressure 130 to 159 mmHg. Similarly, data from the Framingham Heart Study and the Physicians' Health Study emphasize the importance of mild elevations of systolic blood pressure. As age increases the hemodynamic patterns of blood pressure change due to an increase in large artery stiffness, and borderline isolated systolic hypertension becomes the dominant form of hypertension. These facts make the prevention and control of borderline isolated systolic hypertension a key strategic challenge in the effort to prevent excess mortality attributable to blood pressure levels above normal.
More Related Videos
07:30Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
06:04Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
Published on: September 27, 2024
Related Concept Videos
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Hypertension and Regulation of Blood Pressure
Measurement of Blood Pressure
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies